Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Clinical trial NCT05156398 · RECRUITING
Trial details
- NCT number
- NCT05156398
- Sponsor
- Pfizer
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-28
- Primary completion
- 2031-11-29
- Enrollment
- 640
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.